51 related articles for article (PubMed ID: 10988241)
1. Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy.
Lee GH; Badorff C; Knowlton KU
Circ Res; 2000 Sep; 87(6):489-95. PubMed ID: 10988241
[TBL] [Abstract][Full Text] [Related]
2. Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.
Campbell MD; Witcher M; Gopal A; Michele DE
Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1140-50. PubMed ID: 26968544
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.
Bouin A; Vu MN; Al-Hakeem A; Tran GP; Nguyen JHC; Semler BL
J Virol; 2023 Jan; 97(1):e0142622. PubMed ID: 36475766
[TBL] [Abstract][Full Text] [Related]
4. Sarcolemmal fragility secondary to the degradation of dystrophin in dilated cardiomyopathy, as estimated by electron microscopy.
Kawada T; Hemmi C; Fukuda S; Tezuka A; Iwasawa K; Nakazawa M; Sato H; Toyo-Oka T
Exp Clin Cardiol; 2003; 8(2):67-70. PubMed ID: 19641652
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan.
Gastaldello S; D'Angelo S; Franzoso S; Fanin M; Angelini C; Betto R; Sandonà D
Am J Pathol; 2008 Jul; 173(1):170-81. PubMed ID: 18535179
[TBL] [Abstract][Full Text] [Related]
6. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction.
Toyo-Oka T; Kawada T; Nakata J; Xie H; Urabe M; Masui F; Ebisawa T; Tezuka A; Iwasawa K; Nakajima T; Uehara Y; Kumagai H; Kostin S; Schaper J; Nakazawa M; Ozawa K
Proc Natl Acad Sci U S A; 2004 May; 101(19):7381-5. PubMed ID: 15128945
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.
Schips TG; Vanhoutte D; Vo A; Correll RN; Brody MJ; Khalil H; Karch J; Tjondrokoesoemo A; Sargent MA; Maillet M; Ross RS; Molkentin JD
Nat Commun; 2019 Jan; 10(1):76. PubMed ID: 30622267
[TBL] [Abstract][Full Text] [Related]
8. Juvenile cardiomyopathy with dystrophin deficiency.
Luo Y; Shu Q; Wang Y; Gu M; Zhang H; Hong S; Wang R; Yin L
Genes Dis; 2024 May; 11(3):100980. PubMed ID: 38274373
[No Abstract] [Full Text] [Related]
9. Storytelling of Myocarditis.
Thiene G
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672187
[TBL] [Abstract][Full Text] [Related]
10. Burden of Cardiomyopathic Genetic Variation in Lethal Pediatric Myocarditis.
Kontorovich AR; Tang Y; Patel N; Georgievskaya Z; Shadrina M; Williams N; Moscati A; Peter I; Itan Y; Sampson B; Gelb BD
Circ Genom Precis Med; 2021 Aug; 14(4):e003426. PubMed ID: 34228484
[TBL] [Abstract][Full Text] [Related]
11. Increased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine Myocarditis.
Peter AK; Bradford WH; Dalton ND; Gu Y; Chao CJ; Peterson KL; Knowlton KU
PLoS One; 2016; 11(8):e0159971. PubMed ID: 27486657
[TBL] [Abstract][Full Text] [Related]
12. Identification of Glycosylation Sites Essential for Surface Expression of the CaVα2δ1 Subunit and Modulation of the Cardiac CaV1.2 Channel Activity.
Tétreault MP; Bourdin B; Briot J; Segura E; Lesage S; Fiset C; Parent L
J Biol Chem; 2016 Feb; 291(9):4826-43. PubMed ID: 26742847
[TBL] [Abstract][Full Text] [Related]
13. Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.
Townsend D
Anat Rec (Hoboken); 2014 Sep; 297(9):1694-705. PubMed ID: 25125182
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Coxsackievirus-associated dystrophin cleavage prevents cardiomyopathy.
Lim BK; Peter AK; Xiong D; Narezkina A; Yung A; Dalton ND; Hwang KK; Yajima T; Chen J; Knowlton KU
J Clin Invest; 2013 Dec; 123(12):5146-51. PubMed ID: 24200690
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts.
Barnabei MS; Metzger JM
PLoS One; 2012; 7(3):e32880. PubMed ID: 22427904
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.
Townsend D; Turner I; Yasuda S; Martindale J; Davis J; Shillingford M; Kornegay JN; Metzger JM
J Clin Invest; 2010 Apr; 120(4):1140-50. PubMed ID: 20234088
[TBL] [Abstract][Full Text] [Related]
17. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
Heymans S; Hirsch E; Anker SD; Aukrust P; Balligand JL; Cohen-Tervaert JW; Drexler H; Filippatos G; Felix SB; Gullestad L; Hilfiker-Kleiner D; Janssens S; Latini R; Neubauer G; Paulus WJ; Pieske B; Ponikowski P; Schroen B; Schultheiss HP; Tschöpe C; Van Bilsen M; Zannad F; McMurray J; Shah AM
Eur J Heart Fail; 2009 Feb; 11(2):119-29. PubMed ID: 19168509
[TBL] [Abstract][Full Text] [Related]
18. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach.
Yilmaz A; Gdynia HJ; Baccouche H; Mahrholdt H; Meinhardt G; Basso C; Thiene G; Sperfeld AD; Ludolph AC; Sechtem U
J Cardiovasc Magn Reson; 2008 Nov; 10(1):50. PubMed ID: 18983659
[TBL] [Abstract][Full Text] [Related]
19. Acute viral myocarditis.
Dennert R; Crijns HJ; Heymans S
Eur Heart J; 2008 Sep; 29(17):2073-82. PubMed ID: 18617482
[TBL] [Abstract][Full Text] [Related]
20. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.
Badorff C; Knowlton KU
Med Microbiol Immunol; 2004 May; 193(2-3):121-6. PubMed ID: 12920582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
